TrialRheumatology (Oxford, England)2014

Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial.

Hisashi Yamanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.